Human TGFalpha-derived peptide TGFalphaL3 fused with superantigen for immunotherapy of EGFR-expressing tumours

BACKGROUND: Monoclonal antibodies have been employed as targeting molecules of superantigen for the preclinical treatment of a variety of tumours. However, other targeting molecules, such as tumour-related ligands or peptides, are less exploited. Here, we tested other targeting molecules by genetica...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Quanbin, Zhang, Xiaojuan, Yue, Junjie, Liu, Chuanxuan, Cao, Cheng, Zhong, Hui, Ma, Qingjun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018390/
https://www.ncbi.nlm.nih.gov/pubmed/21176167
http://dx.doi.org/10.1186/1472-6750-10-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018390/
https://www.ncbi.nlm.nih.gov/pubmed/21176167
http://dx.doi.org/10.1186/1472-6750-10-91

Ejemplares similares